VANCOUVER, BC / ACCESS Newswire / May 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Pérez is among the ten innovators of the Young Inventors Prize 2025, awarded by the European Patent Office (EPO) on 18 June 2025; MUNICH, May 21, 2025 /PRNewswire/ ...

European Patent Office largely dismisses opposition filed by BioNTech SE, Pfizer Inc., and others in December 2023 challenging validity of EP 4 023 755 B1 and maintains the patent subject to ...

Amid rising global competition, the European Patent Office is stepping up to lead, responding to Europe’s urgent call for innovation and unity by advancing patents, standards, and strategic ...

The European Patent Office (EPO) has announced the top 10 global innovators for the first standalone edition of the Young Inventors Prize 2025. These innovators, known as Tomorrow Shapers, are ...

MUNICH, May 7, 2025 /PRNewswire/ -- The European Patent Office (EPO) has announced the top 10 global innovators for the first standalone edition of the Young Inventors Prize 2025. These innovators ...

Computer technology, which includes areas of AI such as machine learning and pattern recognition, led for the first time, with 16,815 patent applications in 2024. Electrical machinery, apparatus ...

CureVac N.V. CVAC on Thursday said the European Patent Office (EPO) confirmed the validity of CureVac’s European patent EP 3 708 668 B1 subject to amendments to specify the scope of protection.

March 27 (Reuters) - The European Patent Office declared a patent owned by CureVac , opens new tab, valid, after a challenge from drugmaker BioNTech , opens new tab, the company said on Thursday.

Companies and inventors from around the world filed 199,264 patent applications at the European Patent Office (EPO) last year, according to the Patent Index 2024. The U.S. maintained its position as ...